KMK Patient Journey Analysis Leads Global Pharma Brand To More Accurate Forecasting
A top ten pharmaceutical company contracted with KMK Consulting to provide a patient journey analysis on its recently introduced medication serving a small, rare disease patient population suffering with acute myeloid leukemia (AML). Forecasts based on market research of the patient journey were not being met, and senior management needed a reset based on a more evidence-based research approach of the patient journey. KMK was a proven resource to the client, demonstrating […]
